Breast Cancer Trial, By Invitation NCT06881550 Sponsor: Caigang Liu Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, By Invitation

NCT06881550
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who are between 18 and 75 years of age (inclusive).
  • People who are female.
  • People who have been diagnosed with breast cancer confirmed through a laboratory tissue test.
  • People who are expected to have surgery as part of their treatment.
  • People who are expected to live for at least 1 year.
  • People whose bone marrow is functioning well enough, based on blood tests showing adequate levels of white blood cells, platelets, and red blood cells (confirm with trial site for specific values).
  • People whose liver and kidney function meet certain blood test requirements, including healthy levels of liver enzymes, bilirubin, protein, and kidney waste markers (confirm with trial site for specific values).
  • People whose blood clotting function falls within an acceptable range based on standard blood tests (confirm with trial site for specific values).
  • People whose heart is pumping well enough, shown by a heart ultrasound result of at least 50% pumping efficiency.
  • People who have understood the purpose of the study, are willing to follow the trial requirements, and have signed a consent form agreeing to take part.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who cannot tolerate herbal medicines or who are unlikely to follow a herbal medicine treatment plan.
  • People who are unable to swallow, have ongoing diarrhoea, a blocked bowel, or other conditions that would make it difficult to take or absorb medications properly.
  • People with serious problems affecting the heart, liver, kidneys, or other vital organs.
  • People who have serious complications, an active infection, an ongoing fever, a significant risk of bleeding, or problems with blood cell production.
  • People who have a known allergy to any of the ingredients in the treatments used in this trial.
  • People who have a history of immune system problems, including HIV, Hepatitis C, active Hepatitis B, other inherited or acquired immune deficiency conditions, or a history of organ transplant.
  • People who have a history of heart disease, including heart rhythm problems requiring medication, a past heart attack, heart failure, or any other heart condition the trial doctor considers unsuitable for participation.
  • People who are pregnant or breastfeeding, people of childbearing potential who test positive for pregnancy at the start of the trial, or people of childbearing potential who are not willing to use effective contraception throughout the trial.
  • People who, in the trial doctor's judgement, have a serious ongoing medical condition that could affect their safety or ability to complete the study, such as uncontrolled high blood pressure, severe diabetes, or active infection.
  • People who are unconscious, unable to speak or read, unable to communicate normally, or unable to complete questionnaire assessments.
  • People who have a diagnosed neurological or psychiatric condition, including epilepsy or dementia.
  • People with a known or suspected history of alcohol or drug misuse.
  • People who, for any other reason, the trial doctor considers unsuitable for participation.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Sponsor
Caigang Liu
Registry
ClinicalTrials.gov
Start date
30 December 2024
Est. completion
10 December 2025

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Piper Fatigue Assessment score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov